Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HOWL
#3650
Werewolf Therapeutics, Inc. Common Stock
0.6
0
-1.64%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-1.64%
Monthly Change
-11.76%
6 month change
-55.88%
Year Change
-49.15%
Previous Close
0.6
1
Open
0.6
0
Bid
Ask
Low
0.6
0
High
0.6
0
Volume
3
Markets
US Stock Market
Healthcare
HOWL
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
27.65 M
35.28 M
42.74 M
44.83 M
—
Valuation ratios
Enterprise value
171.82 M
-56.99 M
63.96 M
-44.65 M
-90.9 M
Price to earnings ratio
-1.09
-1.1
-4.42
-0.91
-3.42
Price to sales ratio
—
73.96
105.89
163.1
—
Price to cash flow ratio
5.13
1.46
5.07
1.16
4.06
Price to book ratio
1.44
0.48
1.49
0.88
1.64
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
-0.28
-0.34
-0.21
-0.56
-0.73
Return on equity %
-0.33
-0.44
-0.34
-0.96
-1.58
Return on invested capital %
-1 040.55
-935.92
-436.07
-964.14
—
Gross margin %
—
100
100
100
—
Operating margin %
—
-7 007
-2 593.02
-18.49 K
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
-6 726.25
-2 392.32
-17.72 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
13.56
5.84
7.14
7.45
24.72
Inventory turnover
—
—
—
—
—
Asset turnover
—
0
0.01
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
0.19
0.21
0.99
Long term debt to total equity ratio
—
—
0.29
0.36
2.15
Per share metrics
Operating cash flow per share
-2.32
-1.41
-0.91
-1.28
-1.42
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
8.53
4.48
3.77
2.53
7.76
Net current asset value per share
8.73
4.86
3.88
2.58
7.98
Tangible book value per share
8.28
4.24
3.12
1.67
4.53
Working capital per share
8.08
4.03
3.34
2.23
6.65
Book value per share
8.28
4.24
3.12
1.67
4.53
News
Werewolf Therapeutics explores sale and strategic alternatives
Werewolf Therapeutics stock falls after announcing 64% workforce reduction
Werewolf Therapeutics receives Nasdaq notice for minimum bid price deficiency
Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $53,533
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $45,882
H.C. Wainwright slashes Werewolf Therapeutics stock price target on pipeline update
Werewolf reports 30% response rate for WTX-124 in melanoma patients
Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know
MPM BioVentures sells Werewolf Therapeutics (HOWL) stock for $183k
Werewolf Therapeutics (HOWL) former 10% owners sell $183k in stock
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $117k